Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug-Reference-Cited by-同舟云学术

Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug

Published:2013-06 Issue:6 Volume:102 Page:1742-1751
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Brown Jonathan,Chien Caly,Timmins Peter,Dennis Andrew,Doll Walter,Sandefer Erik,Page Richard,Nettles Richard E.,Zhu Li,Grasela Dennis

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. Antiretroviral treatment 2010: Progress and controversies;Gulick;J Acquir Immun Defic Syndr,2010

2. Recent advances in antiretroviral drugs;Ghosh;Expert Opin Pharmacother,2011

3. The survival benefits of AIDS treatment in the United States;Walensky;J Infect Dis,2006

4. Biochemical and genetic characterisations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions;Guo;J Virol,2003

5. Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

2. Development of an extended action fostemsavir lipid nanoparticle;Communications Biology;2024-07-30

3. No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches;Pharmacology Research & Perspectives;2024-07-10

4. Development of a physiologically based pharmacokinetic model of fostemsavir and its pivotal application to support dosing in pregnancy;CPT: Pharmacometrics & Systems Pharmacology;2024-05

5. Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir;BMC Infectious Diseases;2024-02-23